VaultBio Appoints Raffi Siyahian as President, Agency Services and Audience Activation

Audio By Carbonatix

DEL MAR, Calif.--(BUSINESS WIRE)--Jan 15, 2026--

VaultBio announced today that Raffi Siyahian has joined its leadership team as President, Agency Services and Audience Activation, following his leadership tenure at ScoutLife, prior to its 2023 merger with ConcentricLife.

Raffi brings more than two decades of experience building, scaling, and operating agency organizations serving pharmaceutical, biotech, and medical device companies. At ScoutLife, he held senior leadership roles during a period of significant growth, helping establish one of the industry’s most recognized execution platforms in specialty care and rare disease. Earlier in his career, he served in senior strategy leadership roles at McCann Erickson Healthcare Worldwide.

VaultBio supports clients from early pipeline through portfolio and lifecycle strategy spanning market development, clinical, scientific, commercial, and business planning. The firm’s work focuses on surfacing value that is often overlooked, identifying gaps that limit performance, and shaping the decisions that determine how assets and franchises perform from early development through market and sustained lifecycle outcomes.

Agency Services and Audience Activation connect this work to the market. These capabilities translate VaultBio’s strategic conclusions into execution across medical and promotional communications, omnichannel engagement, brand and category activation, and audience-specific experiences for HCP, patient, and consumer audiences.

In his role, Raffi is responsible for scaling and operating these Agency Services and Audience Activation capabilities. His mandate includes defining the operating model, broadening executional offerings, strengthening delivery discipline, and carrying VaultBio’s strategic work into the market in a way that holds up under real-world conditions.

“VaultBio’s strength is its ability to uncover value early and shape the decisions that matter most,” said Joe Young, CEO of VaultBio. “Agency Services and Audience Activation are how that work shows up in the market. Raffi brings the leadership needed to amplify that capability and grow it without compromising quality.”

“What drew me to VaultBio is the clarity of how the work fits together,” said Siyahian. “VaultBio does the heavy lifting upstream. My role is to continue to enhance the teams and systems that take that work into the market and make it function and endure in practice, with the goal of serving to better the lives of our clients’ patients and communities.”

VaultBio’s growth reflects demand from partners who want more than advice on one end or execution on the other. “Our clients want value identified early and carried through delivery without erosion along the way,” said Young. “Raffi’s appointment strengthens our ability to meet that expectation at scale.”

About VaultBio

VaultBio is a strategic advisory firm serving pharmaceutical, biotech, and medical device companies. VaultBio works from molecule through market, supporting clients across market development, clinical, scientific, commercial, and business strategy. The firm focuses on identifying unrealized opportunity, clarifying tradeoffs, and shaping the decisions that determine how assets, portfolios, and franchises succeed. VaultBio’s Agency Services and Audience Activation extend this work into the market through integrated execution across HCP, patient, and consumer audiences.

VaultBio is headquartered in Del Mar, California.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260115291214/en/

CONTACT: Media Contact

Mercedes Marie Lahaie

VaultBio

Email:[email protected]

Phone: 855.483.4838

Website:www.vaultbio.com

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES CONSULTING MARKETING ADVERTISING PROFESSIONAL SERVICES BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH

SOURCE: VaultBio

Copyright Business Wire 2026.

PUB: 01/15/2026 08:00 AM/DISC: 01/15/2026 08:00 AM

http://www.businesswire.com/news/home/20260115291214/en